韩国Jeil制药安装的无菌试验隔离器

2017年12月，一套Wintean品牌无菌检测隔离系统在韩国Jeil制药成功安装。

FAT于2017年11月17日在杭州的Winteam工厂完成。

Jeil制药对该系统的性能非常满意。IQ和OQ通过了韩国FDA。

这是Winteam无菌测试隔离系统在韩国首次安装。我们的团队通过这个项目学习了KGMP和KFDA的法规。

我们高度赞赏我们的最终用户Jeil制药和韩国市场分销商Kosa Bio Inc.。

作为遍历产品的独家销售代理，安提进科技将为滑动客户提供国际标准隔离器解决方案。

关于Jeil制药公司:

1959年成立于1959年，自1988年以来已在KOPI上市。截至2010年，JEIL由961名员工构成，销售额达到4313亿令人朝上。中央研发中心成立于1980年，形成了注册日志的研发活动的核心。目前，截至2010年，新的药物开发研究实验室，综合研究实验室和制剂研究实验室正在积极参与进入创新新药，渐进式修饰的药物和仿制药的完整制造和成分的研究。Jeil’s factory located in Yongin-si, Gyeonggi-do, Korea which was established in 1986 was accredited as fulfilling KGMP in 1987, and produces solid medicines and injections, finished pharmaceutical products including patches, and Active Pharmaceutical Ingredients (APIs) such as anti-biotic ingredients, etc. A new factory with the most up-to-dated facilities which comply with EU-GMP and US-GMP is currently under construction, and is scheduled to be completed in the 4th quarter of 2012. Jeil, equipped with global-class research centers and production facilities, has been recognized for its outstanding value on the world market as well. In the ingredients sector, Jeil exports synthetic ingredients such as Cefditoren Pivoxil, Epinastine HCl, etc. to locations including Japan and China, while also exporting finished products such as Kefentech Plaster (Ketoprofen), Cilapenem Injection (Imipenem / Cilastatin Sodium), etc. to around 30 countries in ASEAN, Central and South America, Africa, etc.